CLINICAL_TRIALS
trial_result
· 2016-10-21
Clinical Trial Update: 0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma [Phase 2]
Summary
Phase 2 trial investigating pentamidine in patients with relapsed or refractory melanoma was terminated; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Melanoma (Skin) | Phase 2 | Status: TERMINATED | Results posted: 2016-10-21